Multi-Phase Cross-modal Learning for Noninvasive Gene Mutation Prediction in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the fourth most common cause of cancer-related death worldwide. Understanding the underlying gene mutations in HCC provides great prognostic value for treatment planning and targeted therapy. Radiogenomics has revealed an association between non-invasive imaging features and molecular genomics. However, imaging feature identification is laborious and error-prone. In this paper, we propose an end-to-end deep learning framework for mutation prediction in APOB, COL11A1 and ATRX genes using multiphasic CT scans. Considering intra-tumour heterogeneity (ITH) in HCC, multi-region sampling technology is implemented to generate the dataset for experiments. Experimental results demonstrate the effectiveness of the proposed model.Comment: Accepted version to be published in the 42nd IEEE Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2020, Montreal, Canad

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis (vol 9, e104158, 2014)

PLOS ONE111United State

Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma

10.3390/cancers13112772CANCERS131

Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients

10.7150/jca.56340JOURNAL OF CANCER12113098-311

Outcome after curative resection of large (≥10 cm) gastric gastrointestinal stromal tumors: How frequent is adjacent organ involvement and is concomitant distal pancreatectomy necessary?

10.1007/s11605-009-1083-4Journal of Gastrointestinal Surgery144607-61

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma

10.1038/s41467-020-20171-7Nature Communications12